This week was big - it was big because of the announcement from NHS England that the Freestyle Libre device would be prescribed across the country according to a common policy without CCGs being able to make up their own rules NHS England Announcement . Is it a victory? I'm not so sure - it should never have got to this point. I hope the policy-makers both regionally and nationally come to acknowledge the reasons behind the situation and resolve to make changes to ensure that something similar doesn't happen again. That will be the lasting legacy created by Partha Kar, Emma Wilmot and many others seen and unseen. As mentioned elsewhere the starting point for the post-April 2019 prescribing is the RMOC Guidance . This isn't the final criteria, but the assertion is that it will enable 20%-25% of T1s to get Libre on prescription - perhaps more, as suggested in this excellent blog piece by Tim Street . So, why not all T1s? Is 25% much too low? Some people have beco
T1 Diabetic ramblings, with a special interest in the Abbott Freestyle Libre Glucose Monitor...and perhaps some totally unrelated musical thoughts.